Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,757 | 1,335 | 1,466 | 1,822 | 1,700 |
| Operating Income | -1,757 | -1,335 | -1,466 | -1,822 | -1,700 |
| Interest Expense | 15 | 16 | 20 | 33 | 11 |
| Other Income | 6 | -44 | 21 | 9 | 33 |
| Pre-tax Income | -1,766 | -1,395 | -1,465 | -1,846 | -1,678 |
| Net Income Continuous | -1,766 | -1,395 | -1,465 | -1,846 | -1,678 |
| Net Income | $-1,766 | $-1,395 | $-1,465 | $-1,846 | $-1,678 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EBITDA(a) | $-1,701 | $-1,282 | $-1,419 | $-1,780 | $-1,657 |